zileuton has been researched along with sulfapyridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bruin, KF; Hommes, DW; Jansen, J; Tytgat, GN; van Deventer, SJ; Wouter ten Cate, J | 1 |
| Awni, WM; Braeckman, RA; Dubé, LM; Granneman, GR; Locke, CS | 1 |
1 trial(s) available for zileuton and sulfapyridine
| Article | Year |
|---|---|
The influence of multiple oral doses of zileuton on the steady-state pharmacokinetics of sulfasalazine and its metabolites, sulfapyridine and N-acetylsulfapyridine.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Interactions; Half-Life; Humans; Hydroxyurea; Lipoxygenase Inhibitors; Male; Middle Aged; Sulfapyridine; Sulfasalazine | 1995 |
2 other study(ies) available for zileuton and sulfapyridine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases.
Topics: Aminosalicylic Acids; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Dexamethasone; Endotoxins; Humans; Hydroxyurea; In Vitro Techniques; Inflammatory Bowel Diseases; Interleukin-1; Interleukin-6; Leukocytes, Mononuclear; Mesalamine; Sulfapyridine; Tumor Necrosis Factor-alpha | 1995 |